Design Therapeutics, Inc. · NASDAQ:DSGN

Point72 Asset Management, L.P.'s stake in Design Therapeutics, Inc. fell to 3.80% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Point72 Asset Management, L.P.'s stake in Design Therapeutics, Inc. fell to 3.80%, 2,366,453 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
3.80%
Shares
2,366,453
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.3.80%2,366,453
Point72 Capital Advisors, Inc.3.80%2,366,453
Steven A. Cohen3.80%2,366,453

Source

View original at SEC

Related